{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:17:14Z","timestamp":1770135434958,"version":"3.49.0"},"reference-count":28,"publisher":"Japanese Society of Hypertension","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1291\/hypres.31.1251","type":"journal-article","created":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T05:55:03Z","timestamp":1219298103000},"page":"1251-1256","source":"Crossref","is-referenced-by-count":16,"title":["The Specific Mineralocorticoid Receptor Blocker Eplerenone Attenuates Left Ventricular Remodeling in Mice Lacking the Gene Encoding Guanylyl Cyclase-A"],"prefix":"10.1291","volume":"31","author":[{"given":"Qingfen","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"SAITO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"NAYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"IMAGAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"SOMEKAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"KAWATA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiji","family":"TAKEDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"UEMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"KISHIMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuwa","family":"NAKAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pitt B, Zannad F, Remme WJ, <i>et al<\/i>: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. <i>N Engl J Med<\/i> 1999; <b>341<\/b>: 709-717.","DOI":"10.1056\/NEJM199909023411001"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000128031.31572.a3"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.29.627"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kuster GM, Kotlyar E, Rude MK, <i>et al<\/i>: Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. <i>Circulation<\/i> 2005; <b>111<\/b>: 420-427.","DOI":"10.1161\/01.CIR.0000153800.09920.40"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT: Remodeling of the rat right and left ventricles in experimental hypertension. <i>Circ Res<\/i> 1990; <b>67<\/b>: 1355-1364.","DOI":"10.1161\/01.RES.67.6.1355"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Rocha R, Rudolph AE, Frierdich GE, <i>et al<\/i>: Aldosterone induces a vascular inflammatory phenotype in the rat heart. <i>Am J Physiol Heart Circ Physiol<\/i> 2002; <b>283<\/b>: H1802-H1810.","DOI":"10.1152\/ajpheart.01096.2001"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1038\/378065a0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Oliver PM, Fox JE, Kim R, <i>et al<\/i>: Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. <i>Proc Natl Acad Sci <NOBR>U S A<\/NOBR><\/i> 1997; <b>94<\/b>: 14731-14735.","DOI":"10.1073\/pnas.94.26.14730"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-199701000-00011"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000029923.57048.61"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.8.3936"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Knowles JW, Esposito G, Mao L, <i>et al<\/i>: Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A&minus;deficient mice. <i>J Clin Invest<\/i> 2001; <b>107<\/b>: 975-984.","DOI":"10.1172\/JCI11273"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hirata Y, Tomita M, Yoshimi H, Kuramochi M, Ito K, Ikeda M: Effect of synthetic human atrial natriuretic peptide on aldosterone secretion by dispersed aldosterone-producing adenoma cells <i>in vitro<\/i>. <i>J Clin Endocrinol Metab<\/i> 1985; <b>61<\/b>: 677-680.","DOI":"10.1210\/jcem-61-4-677"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000057794.29667.08"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Garnier A, Bendall JK, Fuchs S, <i>et al<\/i>: Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase&minus;transgenic mice. <i>Circulation<\/i> 2004; <b>110<\/b>: 1819-1825.","DOI":"10.1161\/01.CIR.0000142858.44680.27"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000203772.78696.67"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117269"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1210\/en.137.10.4145"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T: Salt-induced nephropathy in obese spontaneously hypertensive rats <i>via<\/i> paradoxical activation of the mineralcorticoid receptor. <i>Hypertension<\/i> 2007; <b>50<\/b>: 877-883.","DOI":"10.1161\/HYPERTENSIONAHA.107.091058"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Petez-Rojas JM, Blanco JA, Cruz C, <i>et al<\/i>: Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. <i>Am J Physiol Renal Physiol<\/i> 2007; <b>292<\/b>: F131-F139.","DOI":"10.1152\/ajprenal.00147.2006"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00707.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Tokudome T, Horio T, Kishimoto I, <i>et al<\/i>: Calcineurin&minus;nuclear factor of activated T cells pathway&minus;dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides. <i>Circulation<\/i> 2005; <b>111<\/b>: 3095-3104.","DOI":"10.1161\/CIRCULATIONAHA.104.510594"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Franco V, Chen YF, Feng JA, <i>et al<\/i>: Eplerenone prevents adverse cardiac remodeling induced by pressure overload in atrial natriuretic peptide&minus;null mice. <i>Clin Exp Parmacol Physiol<\/i> 2006; <b>33<\/b>: 773-779.","DOI":"10.1111\/j.1440-1681.2006.04434.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Suzuki J, Iwai M, Mogi M, <i>et al<\/i>: Eplereneone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation. <i>Arterioscler Thromb Vasc Biol<\/i> 2006; <b>26<\/b>: 917-921.","DOI":"10.1161\/01.ATV.0000204635.75748.0f"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000020689.12472.E0"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1161\/hy0202.103268"},{"key":"28","unstructured":"28. Oates JA, Brown NJ: Antihypertensive agents and the drug therapy of hypertension, in Hardman JD and Limbird LE (eds): Goodman &#38; Gilman&rsquo;s the Pharmacological Basis of Therapeutics, 10th ed. New York, McGraw-Hill, 2001, pp 871-900."}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T13:52:50Z","timestamp":1557755570000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.31.1251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.31.1251","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}